🚨 From Specialty Ingredients to LFP Battery Materials
🚨 Sudeep Pharma: From Specialty Ingredients to LFP Battery Materials
Sudeep Pharma Limited is building an interesting dual-engine growth story — combining its established specialty nutrition/pharma ingredients business with a new opportunity in the fast-growing LFP battery materials ecosystem.
📊 FY26 HIGHLIGHTS
• Revenue: ₹642.3 Cr | +28% YoY
• Specialty segment contribution: 34% → 44%
• Net Debt: only ₹33.6 Cr
• ROCE: 22.5%
• ROE: 19.4%
• Working Capital Cycle: 213 days
🔥 WHAT COULD DRIVE THE NEXT PHASE?
🌍 Direct-to-Customer Model
SPL is expanding direct sales in the US and Europe, potentially improving margins while strengthening customer relationships.
🏭 Capacity Expansion
The Nandesari Unit IV adds around 51,200 MT capacity for higher-value molecules including gluconates, glycinates and phosphates.
⚡ LFP Battery Opportunity
Through Sudeep Advanced Materials, the company is entering battery-grade iron phosphate. The Dahej Phase-I plant targets 25,000 MTPA capacity, with commercialisation expected from FY27.
🇮🇪 NSS Ireland Integration
The acquisition provides an established European platform and creates opportunities for supply-chain synergies. NSS currently has significant spare capacity, providing potential operating leverage as utilisation improves.
💰 BALANCE SHEET STRENGTH
One of the key positives is the conservative balance